DekaBank Deutsche Girozentrale’s Haemonetics HAE Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$148K	Hold	2,657	–	–	﹤0.01%	996
2026 Q1	$151K	Hold	2,657	–	–	﹤0.01%	997
2025 Q4	$267K	Hold	2,657	–	–	﹤0.01%	1093
2025 Q3	$126K	Hold	2,657	–	–	﹤0.01%	1197
2025 Q2	$193K	Hold	2,657	–	–	﹤0.01%	1135
2025 Q1	$165K	Hold	2,657	–	–	﹤0.01%	1150
2024 Q4	$208K	Hold	2,657	–	–	﹤0.01%	1141
2024 Q3	$209K	Hold	2,657	–	–	﹤0.01%	1158
2024 Q2	$218K	Hold	2,657	–	–	﹤0.01%	1147
2024 Q1	$220K	Hold	2,657	–	–	﹤0.01%	1139
2023 Q4	$226K	Hold	2,657	–	–	﹤0.01%	1186
2023 Q3	$239K	Buy	2,657 +1,683	+173%	+$150K	﹤0.01%	1159
2023 Q2	$82K	Buy	+974	New	+$82.3K	﹤0.01%	1214
2021 Q2	–	Sell	-1,992	Closed	-$220K	–	1400
2021 Q1	$220K	Hold	1,992	–	–	﹤0.01%	1166
2020 Q4	$233K	Buy	+1,992	New	+$214K	﹤0.01%	1160
2019 Q2	–	Sell	-13,749	Closed	-$1.51M	–	1207
2019 Q1	$1.51M	Buy	+13,749	New	+$1.25M	0.01%	669
2018 Q4	–	Sell	-13,749	Closed	-$1.51M	–	1207
2018 Q3	$1.51M	Buy	13,749 +2,165	+19%	+$224K	0.01%	681
2018 Q2	$1.04M	Buy	+11,584	New	+$978K	0.01%	742

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DekaBank Deutsche Girozentrale's HAE Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its Haemonetics (HAE) position steady in Q2 2026 at 2,657 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #996.

DekaBank Deutsche Girozentrale first reported a position in HAE in Q2 2018 and has held it in 18 quarters since. The position peaked at $1.51M in Q1 2019. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

DekaBank Deutsche Girozentrale held 2,657 shares of Haemonetics worth $148K as of Q2 2026.
DekaBank Deutsche Girozentrale left its Haemonetics share count unchanged in Q2 2026.
Haemonetics made up ﹤0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #996 holding.
DekaBank Deutsche Girozentrale first reported a position in Haemonetics in Q2 2018 and has held it in 18 quarters since.
DekaBank Deutsche Girozentrale's Haemonetics position peaked at $1.51M in Q1 2019.
329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.